Four major cryptocurrency transfers totaling $280.4 million occurred involving Coinbase Institutional over a three-hour period ending Oct. 19 at 11:07 a.m. ET. Bitcoin and Ether were the assets moved, with withdrawals from Coinbase Institutional exceeding deposits by $8 million. The largest single transfer was 982 BTC worth $80.7 million moving into Coinbase Institutional from an unknown wallet. Other transfers included significant Ether and Bitcoin amounts moving both into and out of Coinbase Institutional. These movements indicate active asset shifts but do not clarify if the tokens were sold or how long withdrawn assets will stay off the exchange.
Regarding Coinbase-linked cryptocurrency transfers, here is Pluang's market snapshot as of Oct 20, 2026 04:42 WIB: Among 50 major cryptocurrencies priced on Pluang, 46 rose and 3 fell today. Notable movers include SUSHI (SushiSwap) at Rp3,886 with a 1-day change of +5.05% and Pluang order activity of 55% Sell / 45% Buy, SAND (The Sandbox) at Rp1,065 with +5.04% change and 44% Sell / 56% Buy activity, and XTZ (Tezos) at Rp5,401 with +4.85% change and 0% Sell / 100% Buy activity. Typical hold times range from 100 to 123 days across these assets.
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...
